Calcineurin is essential for survival during membrane stress in Candida albicans

EMBO Journal

Volumn 21, Issue 4, 2002, Pages 546-559

  Cruz, M Cristina ^a   Goldstein, Alan L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antifungal drugs; Calcineurin; Candida albicans; Cyclosporin A; Fluconazole

Indexed keywords

ANTIFUNGAL AGENT; CALCINEURIN; CYCLOSPORIN A; DODECYL SULFATE SODIUM; ERGOSTEROL; FLUCONAZOLE; MEMBRANE LIPID; TACROLIMUS;

ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME INHIBITION; FUNGICIDAL ACTIVITY; GENE MUTATION; LYMPHOCYTE ACTIVATION; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STRESS; T LYMPHOCYTE;

ANTIFUNGAL AGENTS; BASE SEQUENCE; BLOTTING, NORTHERN; CALCINEURIN; CANDIDA ALBICANS; CYCLOSPORINE; DNA PRIMERS; DRUG RESISTANCE, MICROBIAL; FLUCONAZOLE; GENE EXPRESSION REGULATION, FUNGAL; GENES, FUNGAL; METHYLTRANSFERASES; TACROLIMUS;

CANDIDA; CANDIDA ALBICANS; FUNGI;

EID: 0037083792     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/21.4.546     Document Type: Article

References (96)

1. 15N nuclear magnetic resonance backbone assignments and secondary structure of human calcineurin B
2. Calcineurin: From structure to function
3. Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype
4. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans
5. Quantitation of ergosterol content: Novel method for determination of fluconazole susceptibility of Candida albicans
6. Genome-wide expression patterns in Saccharomyces cerevisiae: Comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol
7. Overlapping functions of the yeast oxysterol-binding protein homologues
8. Cell wall integrity modulates RHO1 activity via the exchange factor ROM2
9. Calcineurin is essential in cyclosporin A- and FK506-sensitive yeast strains
10. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
11. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood
12. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole
13. Yeast as model-T cells
14. Mutations that perturb cyclophilin A ligand binding pocket confer cyclosporin A resistance in Saccharomyces cerevisiae
15. Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A
16. Saccharomyces cerevisiae
17. Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans
18. Immunosuppressive and nonimmunosuppressive cyclosporin analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin dependent inhibition of calcineurin
19. Comparison of the roles of calcineurin in physiology and virulence in serotype D and serotype A strains of Cryptococcus neoformans
20. Calcineurin is required for hyphal elongation during mating and haploid fruiting in Cryptococcus neoformans
21. Rapamycin and rapamycin analogs with reduced immunosuppressive activity are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR. Antimicrob
22. 2+ ATPases
23. 2+ ATPases in Saccharomyces cerevisiae
24. 2+/calmodulin-dependent phosphoprotein phosphatases is required for adaptation to pheromone
25. Yeast has homologs (CNA1 and CNA2 gene products) of mammalian calcineurin, a calmodulin-regulated phosphoprotein phosphatase
26. Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray
27. Cell wall perturbation in yeast results in dual phosphorylation of the Slt2/Mpk1 MAP kinase and in an Slt2-mediated increase in FKS2-lacZ expression, glucanase resistance and thermotolerance
28. Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/Caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans
29. Cell wall stress depolarizes cell growth via hyperactivation of RHO1
30. Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter
31. A single-transformation gene function test in diploid Candida albicans
32. Cloning and sequence analysis of a rapamycin-binding protein-encoding gene (RBP1) from Candida albicans
33. Calcineurin mediates inhibition by FK506 and cyclosporin of recovery from α-factor arrest in yeast
34. Calcineurin regulatory subunit is essential for virulence and mediates interactions with FKBP12-FK506 in Cryptococcus neoformans
35. The yeast gene ERG6 is required for normal membrane function but is not essential for biosynthesis of the cell-cycle-sparking sterol
36. Regulation of the mevalonate pathway
37. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex
38. Inhibition of calcineurin by cyclosporin A-cyclophilin requires calcineurin B
39. FK506-binding protein proline rotamase is a target for the immunosuppressive agent FK506 in Saccharomyces cerevisiae
40. Immunosuppressant target protein FKBP12 is required for P-glycoprotein function in yeast
41. Calcineurin: Structure, function, and inhibition
42. +-ATPase assembly
43. Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors
44. Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein
45. Functional domain structure ofcalcineurin A: Mapping by limited proteolysis
46. Cryptococcus neoformans infection in organ transplant recipients: Variables influencing clinical characteristics and outcome
47. MKK1 and MKK2, which encode Saccharomyces cerevisiae mitogen-activated protein kinase-kinase homologs, function in the pathway mediated by protein kinase C
48. Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: Drug susceptibility studies in erg6 mutants
49. Genome-wide analysis of gene expression regulated by the yeast cell wall integrity signalling pathway
50. Activation of yeast protein kinases C by Rho1 GTPase
51. The yeast multidrug resistance pump. Pdr5p, confers reduced drug resistance in erg mutants of Saccharomyces cerevisiae
52. Interaction of FKBP12-FK506 with calcineurin A at the B subunit-binding domain
53. Positive and negative regulation of squalene synthase (ERG9), and ergosterol biosynthetic gene, in Saccharomyces cerevisiae
54. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex
55. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin
56. Modulation of fluconazole sensitivity by the interaction of mitochondria and Erg3p in Saccharomyces cerevisiae
57. An FK506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones
58. Four cholesterol -sensing proteins
59. A novel sequence element is involved in the transcriptional regulation of expression of the ERG1 (squalene epoxidase) gene in Saccharomyces cerevisiae
60. A yeast mitogen-activated protein kinase homolog (Mpk1p) mediates signalling by protein kinase C
61. Specific interaction of the cyclophilin-cyclosporin complex with the B subunit of calcineurin
62. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
63. Transcriptional analyses of antifungal drug resistance in Candida albicans
64. Synergic effects of tacrolimus and azole antifungal agents against azole-resistant Candida albicans strains
65. Fluconazole plus cyclosporine: A fungicidal combination effective against experimental endocarditis due to Candida albicans
66. Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans
67. The latch region of calcineurin B is involved in both immunosuppressant-immunophilin complex docking and phosphatase activation
68. Cyclosporin A inhibits the growth of Cryptococcus neoformans in a murine model
69. Treatment of murine cryptococcosis with cyclosporin-A in normal and athymic mice
70. Transformation of yeast with synthetic oligonucleotides
71. Transformation of yeast directly with synthetic oligonucleotides
72. 2+-calmodulin-dependent protein kinase
73. Protein phosphatase type 2B (calcineurin)-mediated, FK506-sensitive regulation of intracellular ions in yeast is an important determinant for adaptation to high salt stress conditions
74. Calcineurin is required for virulence of Cryptococcus neoformans
75. The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein
76. Effects of cyclosporine in experimental cryptococcal meningitis
77. Wsc1 and Mid2 are cell surface sensors for cell wall intergrity signaling that act through Rom2, a guanine nucleotide exchange factor for Rho1
78. Mid2 is a putative sensor for cell integrity signaling in Saccharomyces cerevisiae
79. Improved calcineurin inhibition by yeast FKBP12-drug complexes. Crystallographic and functional analysis
80. Human P-glycoprotein transports cyclosporin A and FK506
81. The mechanism of action of cyclosporin A and FK506
82. Getting started with yeast
83. Differential regulation of cell wall biogenesis during growth and development in yeast
84. Coadministration of ketoconazole and cyclosporine for kidney transplant recipients: Long term follow-up and study of metabolic consequences
85. An improved protocol for the preparation of yeast cells for transformation by electroporation
86. Sensitivity to cyclosporin A is mediated by cyclophilin in Neurospora crassa and Saccharomyces cerevisiae
87. Upc2p and Ecm22p, dual regulators of sterol biosynthesis in Saccharomyces cerevisiae
88. Two cyclophilin A homologs with shared and distinct functions important for growth and virulence of Cryptococcus neoformans
89. Identification in the calcineurin A subunit of the domain that binds the regulatory B subunit
90. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increase in azole resistance in Candida albicians isolates from a patient infected with human immunodeficiency virus
91. Stable azole drug resistance associated with substrain of Candida albicans from an HIV-infected patient
92. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance
93. Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions
94. 2+ signal is to activate calcineurin
95. Strand-specificity in the transformation of yeast with synthetic oligonucleotides
96. + in fission yeast: Mutant defects in cytokinesis, cell polarity, mating and spindle pole body positioning